Insider · CIK 0002002238
David K Lee
Files at ITOS (iTeos Therapeutics, Inc.). First filing -, latest -.
David K Lee files SEC Form 4 as director at ITOS (iTeos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David K Lee has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -21,141 | - | - | 0 | Aug 29, 2025 |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -23,625 | - | - | 0 | Aug 29, 2025 |
Questions about David K Lee
Answered from the filings on this page, as of the latest one.
Is David K Lee buying or selling?
David K Lee has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David K Lee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David K Lee has 0.
Where does David K Lee file Form 4?
David K Lee has filed Form 4 at ITOS (iTeos Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.